Effect of tafamidis on left atrial function in patients with transthyretin amyloid cardiomyopathy

被引：0

作者：

Uemura, K. ^{[1
]}

Ichikawa, Y. ^{[1
]}

Nagai, S. ^{[1
]}

Takeuchi, M. ^{[1
]}

Nishihara, Y. ^{[1
]}

Takeuchi, K. ^{[1
]}

Oota, E. ^{[1
]}

Odajima, S. ^{[1
]}

Kintsu, M. ^{[1
]}

Todo, S. ^{[1
]}

Fukuda, T. ^{[1
]}

Hisamatsu, E. ^{[1
]}

Hirata, K. ^{[1
]}

Tanaka, H. ^{[1
]}

机构：

[1] Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Kobe, Japan

来源：

EUROPEAN HEART JOURNAL | 2024年 / 45卷

关键词：

D O I：

10.1093/eurheartj/ehae666.2075

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[1] Effect of tafamidis on left atrial function of patients with transthyretin amyloid cardiomyopathy
Uemura, Koya
Ichikawa, Yasushi
Nagai, Shun
Nishihara, Yu
Todo, Saki
Oota, Eri
Odajima, Susumu
Takeuchi, Kimikazu
Kintsu, Masayuki
Fukuda, Terunobu
Hisamatsu, Eriko
Hirata, Ken-ichi
Tanaka, Hidekazu
HEART AND VESSELS, 2024, 39 (09) : 810 - 817
[2] Tafamidis and Incidence of Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy
Girvin, Zachary P.
Sweat, Austin O.
Kochav, Stephanie M.
Maurer, Mathew S.
Dizon, Jose
Wan, Elaine Y.
Biviano, Angelo
Garan, Hasan
Yarmohammadi, Hirad
JACC-CLINICAL ELECTROPHYSIOLOGY, 2023, 9 (04) : 586 - 587
[3] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
Rettl, Rene
Duca, Franz
Binder, Christina
Capelle, Christophe
Aschauer, Stefan
Mascherbauer, Julia
Hengstenberg, Christian
Bonderman, Diana
WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : 315 - 316
[4] Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, Mathew S.
Schwartz, Jeffrey H.
Gundapaneni, Balarama
Elliott, Perry M.
Merlini, Giampaolo
Waddington-Cruz, Marcia
Kristen, Arnt V.
Grogan, Martha
Witteles, Ronald
Damy, Thibaud
Drachman, Brian M.
Shah, Sanjiv J.
Hanna, Mazen
Judge, Daniel P.
Barsdorf, Alexandra I.
Huber, Peter
Patterson, Terrell A.
Riley, Steven
Schumacher, Jennifer
Stewart, Michelle
Sultan, Marla B.
Rapezzi, Claudio
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11): : 1007 - 1016
[5] Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
Rettl, R. Rene
Mann, C.
Duca, F.
Dachs, T-M
Binder, C.
Kronberger, C.
Dusik, F.
Ligios, L. Camuz
Schrutka, L.
Dalos, D.
Charwat-Resl, S.
Kastner, J.
Eslam, R. Badr
Bonderman, D.
EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 252 - 253
[6] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
Rettl, R.
Duca, F.
Binder, C.
Capelle, C.
Aschauer, S.
Eslam, R. Badr
Mascherbauer, J.
Hengstenberg, C.
Bonderman, D.
EUROPEAN HEART JOURNAL, 2019, 40 : 494 - 494
[7] Treatment with Tafamidis in patients with transthyretin amyloid cardiomyopathy
Rettl, R.
Christopher, M.
Dachs, T.
Duca, F.
Binder, C.
Dusik, F.
Seirer, B.
Eslam, R. Badr
Hengstenberg, C.
Bonderman, D.
WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S306 - S307
[8] Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
Rettl, R.
Christopher, M.
Duca, F.
Dachs, T.
Binder, C.
Kronberger, C.
Dusik, F.
Ligios, L. Camuz
Schrutka, L.
Dalos, D.
Charwat-Resl, S.
Eslam, R. Badr
Hengstenberg, C.
Kastner, J.
Bonderman, D.
WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 3) : S115 - S115
[9] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
Rettl, Rene
Duca, Franz
Binder, Christina
Capelle, Christophe
Eslam, Roza Badr
Aschauer, Stefan
Mascherbauer, Julia
Hengstenberg, Christian
Bonderman, Diana
WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : S452 - S452
[10] Tafamidis for Transthyretin Amyloid Cardiomyopathy
不详
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 773 - 773

← 1 2 3 4 5 →